Deadly, Drug Resistant Fungus Could Be Next Global Threat

Henrietta Strickland
April 9, 2019

What makes it deadly is that it is a drug-resistant fungus.

The symptoms are similar to flu-like conditions - fever, aches, and fatigue - and the "superbugs" resistant to medicine are most problematic for people, fatal even, with weak immune systems, particularly newborns, the elderly, and diabetics, according to the report.

An article published in the New York Times claimed the deadly fungus has recently reached New York, New Jersey and IL, prompting the US Centers for Disease Control and Prevention (CDC) to add it to the list of risky and violent bacteria.

The man at Mount Sinai died after 90 days in the hospital, but C. auris did not.

Candida Auris is considered to be particularly problematic because it is resistant to antifungal drugs now available.

Healthy people with immune systems in top shape are believed to be in very low risk of getting an infection, according to Forbes.

India, Pakistan, China, Japan, Russia, Australia, US, Canada, Britain, France, Germany, Spain, South Africa, Kenya and list goes on with at least 587 cases reported from US alone, 309 cases in NY, 104 in New Jersey and 144 in IL, according to the CDC.

The Brooklyn patient died 90 days after being admitted to hospital, but the Candida Auris did not disappear.

The third case involved an American man who was touring Bangladesh in late 2016.

"Based on information from a limited number of patients, 30-60 percent of people with C. auris infections have died".

New Jersey had another 105 confirmed cases.

There has been little coverage on this global outbreak, mostly because many hospitals and governments are reluctant to disclose such outbreaks for fear of being seen as infection hubs, The New York Times reported.

Members of the public remained in the dark until a scientific paper reported that there was "an ongoing outbreak of 50 C. auris cases" in July 2016.

- Federal health authorities are warning about an emerging fungu that presents a serious global health threat and is showing up in NY and New Jersey.

Some hospitals and medical professionals have argued that since precautions are being taken to prevent the spread of such outbreaks, publicising an outbreak would scare people unnecessarily, The New York Times said.

Because symptoms can vary greatly, a laboratory test is needed to determine whether a patient has a C. auris infection.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER